|
Iodine-125 (I-125)
Physical Data:
- Gamma Energy
- X-ray Energy
- Radioactive Half
Life
- Effective Half Life
- Biological Half Life
|
35
keV
27-32 keV
59.6 days
42 days
120-138 days |
Radiological Data:
- Critical organ: thyroid
- Internal exposure through inhalation,
ingestion, or absorption are primary
concerns
Shielding:
Dose Information (assume
point source):
- 100 cm from 1mCi -
0275 mr/hr
- 10 cm from 1mCi -
27.5 mr/hr
- 1 cm from 1mCi - 2750
mr/hr
Survey Instrumentation:
- NaI scintillation probe
- Liquid scintillation counter (LSC)
- Ls window: 0 to 850
- LS efficiency: 78%
Regulatory Compliance:
|
|
400 µCi:
(by ingestion)
600 µCi: (by inhalation) |
|
|
3 x 10 -8 µCi/mL |
Special Considerations:
Volatilization of iodine is the most
significant problem with this isotope. Simply
opening a vial of sodium [I-125] iodide at
high radioactive concentration can cause
minute droplets of up to 100Bq to become
airborne. Solutions
containing iodide ions should not be made
acidic nor stored frozen: both lead to formation
of volatile elemental iodine. As some
iodocompounds can penetrate surgical rubber
gloves it is advisable to wear two pairs,
or polyethylene gloves over rubber. In
the event of suspected or actual significant
contamination of personnel the thyroid should
be blocked by administration of stable iodine
as, for example, tablets of potassium iodate
(170mg) or potassium iodide (130mg). To
render any spilled iodine-125 chemically
stable the area of the spill should be trated
with alkaline sodium thiosulfate solution
prior to commencing decontamination.
|